Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ji, Linong ^a   Tong, Xiaolin ^b   Wang, Hongyuan ^c   Tian, Haoming ^d   Zhou, Huimin ^e   Zhang, Lili ^f   Li, Qifu ^g   Wang, Yizhong ^h   Li, Hongmei ⁱ   Liu, Min ^j   Yang, Hongjie ^k   Gao, Yanbin ^l   Li, Yan ^m   Li, Quanmin ⁿ   Guo, Xiaohui ^o   Yang, Gangyi ^p   Zhang, Zhongai ^q   Zhou, Zhiguang ^r   Ning, Guang ^s   Chen, Yingli ^a   Paul, Sanjoy ^t   more..

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d SICHUAN UNIVERSITY   (China)

^e HEBEI MEDICAL UNIVERSITY   (China)

^f PEKING UNIVERSITY THIRD HOSPITAL   (China)

^g THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^h CHINA AEROSPACE SCIENCE AND INDUSTRY CORPORATION   (China)

ⁱ CHINA MEITAN GENERAL HOSPITAL   (China)

^j GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^k SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^l INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^m SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

ⁿ CHINESE PLA GENERAL HOSPITAL   (China)

^o PEKING UNIVERSITY FIRST HOSPITAL   (China)

^p THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^q Nanjing Hospital of Traditional Chinese Medicine   (China)

^r CENTRAL SOUTH UNIVERSITY   (China)

^s SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^t UNIVERSITY OF QUEENSLAND   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HERBACEOUS AGENT; METFORMIN; UNCLASSIFIED DRUG; XIAOKE;

ADULT; ARTICLE; CHINESE MEDICINE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84874512103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056703     Document Type: Article

References (30)

1. Cheng JT, (2000) Review: drug therapy in Chinese traditional medicine. The Journal of Clinical Pharmacology 40: 445-450.
2. Zhang H, Tan C, Wang H, Xue S, Wang M, (2010) Study on the history of Traditional Chinese Medicine to treat diabetes. Eur J of Integr Med 2: 41-46.
3. Ni MS (1995) The Yellow Emperor's Classic of Medicine: A New Translation of the NeijingSuwen with Commentary. Boston, MA: Shambhala Publications. 316 p.
4. Cang Chung-Ching HH (1983) Chin Kuei You Lueh. Long Beach: Oriental Healing Arts Institute: 240 p.
5. Hsu HY, (1978) Chinese herb therapy for diabetes mellitus. Bull of the Oriental Healing Arts Inst 3: 12-17.
6. Sena M, Chuang G, Tam W, Tam G, Tam C, (2009) Survey of biological active molecules in the Chinese traditional herbal formula LiuWeiDiHuangWan for the treatment of Type II Diabetes. FASEB J 23: 900-905.
7. Zhang Y, Ma Y, Zhou W, Chen J, Wei C, (2004) Effect of LiuweiDihuang decoction on the function of hypothalamus-pituitary-ovary axis in senescence-accelerated mouse. Int Congress Ser 1260: 421-426.
8. Li WL, Zheng HC, Bukuru J, Kimpe ND, (2004) Natural medicines used in the traditional Chinese medical system fortherapy of diabetes mellitus. J Ethnopharmacol 92: 1-21.
9. Liu JP, Zhang M, Wang WY, Grimsgaard S, (2004) Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Database Syst Rev 3: CD003642.
10. Xie WD, Zhao Y, Zhang Y, (2011) Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus. Evidence-Based Complementary and Alternative Medicine pp. 726723.
11. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS, (2003) Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26: 1277-1294.
12. Ye TS (2006) Record of medical practice. Beijing: People's Medical Publishing House. 553 p.
13. Zhu DX, Yang SZ (1993) The Heart and Essence of Dan-xi's Methods of Treatment. Boulder, CO: Blue Poppy Press. 450 p.
14. Pharmacopoeia Commission (2010) Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science and Technology Press. 1248 p.
15. Li M, Fisette A, Zhao XY, Deng JY, Mi J, et al. (2009) Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes 33: 424-439.
16. Zheng X (2010) Principal Guideline For the Development of New Traditional Chinese Medicine. Beijing: China Medical Science Press. 727 p.
17. Home PD, Jones NP, Pocock SJ, Beck-Nielsen H, Gomis R, et al. (2007) Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med 24: 626-634.
18. Kenward MG, Carpenter J, (2007) Multiple imputation: current perspectives. Stat Methods Med Res 16: 199-218.
19. Demidenko E (2004) Mixed models: theory and applications. Hoboken, NJ: Wiley. 736 p.
20. Sang Z, Zhou L, Fan X, McCrimmon RJ, (2010) Radix astragali (huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes. Am J Chin Med 38: 1027-1038.
21. Xu XH, Zheng XX, (2008) Effects of Puerarin on the Levels of Calcium and Nitric Oxide in Cultured H ippocampal Neurons during Oxygen-G lucose Deprivation. Chin Pharm J 43: 1308-1312.
22. Zhou R, Guo JJ, Yin CM, Li TK, (2003) Clinical observations of Xiaoke Wan in treatment of type 2 diabetic patients(Qi and Yin deficiency zheng). Zhong guoYao Wu Yu Lin Chuang 3: 131-132.
23. Zhang HZ, (1999) Clinical observation into Xiaoke Wan in the treatment of 86 cases of type 2 diabetic patients. Zhong Yi Yao Yan Jiu 15: 19-21.
24. Zhao YC, Hou M, (1998) Xiaoke Wan in treatment of 200 cases of type 2 diabetic patients. Changchun Zhong Yi Xue Yuan Xue Bao 14: 15.
25. Chen G, Ni YD, Lai XM, Liang HQ, (2003) Clinical study on Xiaoke Wan in treating type 2 diabetes mellitus with Qiand Yin Defiency. Zhong Yao Xin Yao Yu Lin Chuang Yao Li 14: 84-86.
26. Wu JL, (2005) Observations into the effects of Xiaoke Wan in treatment of diabetes. Shi Yong Zhong Xi Yi Jie He Lin Chuang 5: 18-19.
27. Wang G, Mao B, Xiong ZY, Fan T, Chen XD, et al. (2007) The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: A Survey of 13 Randomly Selected Journals from Mainland China. Clin ther 29: 1456-1467.
28. European Medicines Agency (2005) Public statement on the risk associated with the use of herbal products containing Aristolochia species. Available: http://www.emea.europa.eu/pdfs/human/hmpc/13838105en.pdf. Accessed 2008 Jul 10.
29. Tang JL, Zhan SY, Ernst E, (1999) Review of randomised controlled trials of traditional Chinese medicine. BMJ 319: 160-161.
30. Wang E, Wylie-Rosett J, (2008) Review of selected Chinese herbal medicines in the treatment of type 2 diabetes. Diabetes Educ 34: 645-654.